Recent advances in spatio-temporally controllable systems for management of glioma

Huiwen Zhang1, Wanqi Zhu1, Wei Pan1

  • 1College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan 250014, China.

Insights

Spatio-temporally controllable therapies offer a promising approach to treating malignant glioma by precisely targeting tumor cells. This review explores advancements in drug delivery systems for precise glioma treatment, minimizing side effects.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Drug Delivery Systems

Background:

  • Malignant glioma is an aggressive brain tumor with poor outcomes despite conventional treatments.
  • Current therapies lack specificity, leading to significant side effects.
  • Spatio-temporally controllable approaches are emerging as a promising strategy for targeted glioma treatment.

Purpose of the Study:

  • To review recent advancements in drug delivery systems for spatio-temporally controllable glioma treatment.
  • To focus on the mechanisms and design principles of sensitizers used in these therapies.
  • To discuss challenges and future clinical applications of controllable glioma therapies.

Main Methods:

  • Literature review of recent research on spatio-temporally controllable drug delivery for glioma.
  • Analysis of mechanisms and design principles of sensitizers for targeted therapy.
  • Discussion of challenges and potential clinical applications.

Main Results:

  • Spatio-temporally controllable systems offer precise targeting, minimally invasive treatment, and on-demand application.
  • External stimuli can be adjusted to maximize cytotoxicity to glioma while sparing normal tissues.
  • Removability of stimuli allows for reduced side effects and improved patient outcomes.

Conclusions:

  • Recent advancements show significant potential for spatio-temporally controllable therapies in treating malignant glioma.
  • Further research into sensitizer design and clinical translation is needed.
  • These approaches may revolutionize glioma treatment by offering enhanced efficacy and reduced toxicity.